Adimmune's Quadrivalent Flu Vaccine Approved by TFDA

TAIPEI, , May 10, 2017 /PRNewswire/ -- Taiwan-based vaccine provider Adimmune (4142.TT) successfully obtained approval of its quadrivalent flu vaccine (ADIMFLU-S(QIS)) from Taiwan FDA. Adimmune will start the commercial production of quadrivalent flu vaccine in 2017 and supply the domestic out...